3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Breast Neoplasms
11
Prostatic Neoplasms
4
Colorectal Neoplasms
4
Neoplasm Metastasis
3
Lymphoma
3
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Papillomavirus Infections
2
Pancreatic Neoplasms
2
Ovarian Neoplasms
2
Obesity-Related Malignant Neoplasm
2
Motor Activity
2
Hematologic Neoplasms
2
Ventricular Dysfunction, Left
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Smoking Cessation
1
Skin Carcinoma
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
No Evidence of Disease
1
New Healthcare Approach
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Hodgkin Disease
1
Interventions
venetoclax
26
ibrutinib
23
Rituximab
22
Cyclophosphamide
21
obinutuzumab
18
acalabrutinib
18
fludarabine phosphate
13
fludarabine
13
zanubrutinib
8
Bendamustine Hydrochloride
8
pirtobrutinib
7
Biopsy
7
Specimen Handling
6
Lenalidomide
6
CT-P10
6
Whole-Body Irradiation
5
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Mycophenolic Acid
4
duvelisib
3
Melphalan
3
Chlorambucil
3
Busulfan
3
idelalisib
2
daratumumab
2
Vincristine
2
Prednisone
2
Patient Reported Outcome Measures
2
Observation
2
Mesna
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Leukemia, Lymphocytic, Chronic, B-Cell
×
Methods
×
Clear all
NCT06396611
2025-03-19
ADRENALINE
Universidade do Porto
Phase NA
Active not recruiting
11 enrolled